Home
iwCAR-T is an annual workshop/think-tank bringing together leading international clinical and translational research minds in CAR-T and cell therapies for both solid and blood cancers in a face-to-face forum.
Related Articles
Understanding the concept of MGRS
Nelson Leung, MD, Mayo Clinic, Rochester, MN, discusses monoclonal gammopathy of renal significance (MGRS), a classification of B-cell or plasma-cell clonal disorders that results in…
Case Study: AML diagnosis, classification, risk-stratification and treatment
Sanam Loghavi and Naval Daver discuss the current approach to the diagnosis and classification, risk-stratification and treatment options for newly diagnosed AML in the context…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Acquired mutations associated with resistance to BTKi in patients with CLL
Stephan Stilgenbauer, MD, University of Ulm, Ulm, Germany, discusses acquired mutations that underlie resistance to BTK inhibitors (BTKi) in patients with chronic lymphocytic leukemia (CLL).…
FDA approves cilta-cel for adult patients with R/R multiple myeloma after at least one prior line of therapy
On April 5th, 2024, the U.S. Food and Drug Administration (FDA) granted approval to ciltacabtagene autoleucel (cilta-cel), a B-cell maturation…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
The importance of cardio-oncology, awareness around the ESC 2022 guidelines & building a multidisciplinary team | VJHemOnc
Welcome to The VJ Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). In this exclusive session, leading experts Daniel…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta, MD, PhD, Vall d´Hebron University Hospital, Barcelona, Spain, discusses the results of the first-in-human Phase I study (NCT04240704) investigating the safety and efficacy…
Antigen loss as a key driver of resistance to anti-BCMA T-cell therapies in myeloma
Paola Neri, MD, PhD, University of Calgary, Calgary, Canada, comments on antigen loss as a key driver of resistance to anti-BCMA CAR T-cell therapy and…